Go Unlimited with Magzter GOLD

Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just

$149.99

$74.99/Year

Try GOLD - Free

Ozempic Pill Fails Alzheimer's Test

The Wall Street Journal

November 25, 2025

Novo Nordisk stock falls after setback in effort to expand uses for its obesity drug

- BY PETER LOFTUS AND ADRIA CALATAYUD

Novo Nordisk shares fell sharply after the Danish drugmaker said a pill with the key ingredient in Ozempic and Wegovy didn't slow Alzheimer's disease in two late stage clinical trials.

This story is from the November 25, 2025 edition of The Wall Street Journal.

Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.

Already a subscriber? Sign In